Page last updated: 2024-11-01

ofloxacin and Bile Duct Neoplasms

ofloxacin has been researched along with Bile Duct Neoplasms in 1 studies

Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

Bile Duct Neoplasms: Tumors or cancer of the BILE DUCTS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Halm, U1
Fleig, WE1
Mössner, J1
Keim, V1

Trials

1 trial available for ofloxacin and Bile Duct Neoplasms

ArticleYear
Ofloxacin and ursodeoxycholic acid versus ursodeoxycholic acid alone to prevent occlusion of biliary stents: a prospective, randomized trial.
    Endoscopy, 2001, Volume: 33, Issue:6

    Topics: Aged; Anti-Infective Agents; Bile Duct Neoplasms; Cholagogues and Choleretics; Cholestasis, Extrahep

2001